Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    L-Tyrosine API

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Guardant Health & Blueprint Medicines present real-world data at IASLC 2022
    Guardant Health & Blueprint Medicines present real-world data at IASLC 2022

    08 Aug 2022

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20220808005172/en

    BUSINESS WIRE
    08 Aug 2022
    Share Share
    InnoCare Announces 1st Subject Dosed in Clinical Trial of TYK2 JH2
    InnoCare Announces 1st Subject Dosed in Clinical Trial of TYK2 JH2

    01 Aug 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220801005488/en

    BUSINESSWIRE
    01 Aug 2022
    Share Share
    InnoCare's Clinical Trial of ICP-189 gets approval in China
    InnoCare's Clinical Trial of ICP-189 gets approval in China

    19 Oct 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/innocare-announces-approval-of-clinical-trial-of-novel-shp2-allosteric-inhibitor-icp-189-in-china-301402956.html

    PRNEWSWIRE
    19 Oct 2021
    Share Share
    Antifungal out, cancer in: Revolution scores $500M Sanofi deal
    Antifungal out, cancer in: Revolution scores $500M Sanofi deal

    18 Jul 2018

    // Brittany Meiling ENDPTS

    https://endpts.com/antifungal-out-cancer-in-revolution-scores-500m-sanofi-deal-on-first-oncology-program/

    Brittany Meiling ENDPTS
    18 Jul 2018
    Share Share
    Exelixis links with BMS to test potential cancer combo
    Exelixis links with BMS to test potential cancer combo

    01 Mar 2017

    // Selina McKee PHARMATIMES

    http://www.pharmatimes.com/news/exelixis_links_with_bms_to_test_potential_cancer_combo_1187753

    Selina McKee PHARMATIMES
    01 Mar 2017
    Share Share
    BMS buys back early oncology rights from Asia partner
    BMS buys back early oncology rights from Asia partner

    11 Aug 2016

    // Stacy Lawrence FIERCE BIOTECH

    http://www.fiercebiotech.com/biotech/bms-buys-back-early-oncology-rights-from-asia-partner

    Stacy Lawrence FIERCE BIOTECH
    11 Aug 2016
    Share Share